Investment Banking

The Investment Banking team at Stephens offers a full-range of services to an array of sectors and industries, from consumer and healthcare to energy and technology.

Stephens Investment Banking For The Middle Market - Sectors

The Stephens Investment Banking team focuses on an expanding range of industries, from consumer and healthcare to energy and technology. In each area of focus, we combine in-depth industry knowledge with strong execution.

Stephens Healthcare Services and Life Sciences Group is devoted to assisting small to mid-cap high-growth companies that are reshaping the healthcare industry. Across industry sectors, our investment banking clients provide innovative services or offer technologies with large addressable markets positioned to improve the quality or reduce the cost of healthcare. Through our focused industry approach, we offer our clients a range of investment banking designed to help them reach their strategic objectives.

Stephens has executed numerous M&A transactions in the healthcare services and life sciences sectors with a total transaction value in excess of $1 billion. In addition to our M&A experience, we have recently acted as placement agent, lead-managed or co-managed equity and debt offerings with a total offering value exceeding $1 billion. Segments of the healthcare services and life sciences sector that we follow include:

Healthcare Services


  • Hospitals (Acute and Specialty)
  • Assisted Living
  • Skilled Nursing Facilities

Alternate Site, Ancillary and Outsourcing

  • Ambulatory Surgery
  • Dialysis
  • Oncology / Imaging
  • Outpatient Rehabilitation
  • Home Health / Hospice
  • Workplace
  • Clinical Outsourcing
  • Financial Outsourcing

Pharmaceutical Services, Distribution and Healthcare IT

  • Specialty Distribution
  • Institutional Pharmacy
  • GPOs
  • Specialty HIT
  • Data Analytics
  • Outsourcing
  • Ancillary Companies


  • Specialty Managed Care / Cost Containment
  • Workers' Compensation
  • Disease Management

Life Sciences/ Medical Technologies

  • Ag Biotech and Animal Health Technology
  • Biologics
  • Diagnostic and Clinical Laboratories
  • Diagnostic Tools and Platforms
  • Drug Discovery and Development
  • Cardiovascular
  • Dental
  • Medical Equipment
  • mHealth
  • Orthopedics
  • Ophthalmology
  • Patient Monitoring
  • Women's Health
Skip Clemmons
Managing Director (501) 377-2388
Little Rock, AR
Shawn Fitz
Managing Director (501) 377-8049
Little Rock, AR
Simon Bagnall
Senior Vice President (501) 377-2425
Little Rock, AR
Stuart Irby
Vice President (501) 377-2358
Little Rock, AR

$200 Million

Follow-On Offering


$124 Million

Follow-On Offering


$125 Million

Follow-On Offering


Not disclosed

Has Been Acquired by

BioMerics, LLC


$650 Million

Convertible Senior Notes


$40 Million

Follow-On Offering


$60 Million

Has Divested

its Cardiothoracic closure business to A&E Medical


$138 Million

Follow-On Offering

Joint Bookrunner

$150 Million

Senior Secured Credit Facility


See all related transactions

(800) 643-9691 | Member NYSE, SIPC

© 2018 Stephens Inc. All rights reserved.